Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies
21st February 2019: Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announced a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines. Valitacell’s novel in-line analytical profiling technologies and its data-driven/machine learning approach, together with Solentim’s …